| Title |
Author(s) |
Journal |
Issue Date |
Type |
|
Development and validation of systems for rational use of viral load testing in adults receiving first-line ART in sub-Saharan Africa
|
Menten, J.; Kiragga, A.; Lynen, L.; Robertson, G.; Castelnuovo, B.; Manabe, Y. C.; Reynolds, S. J.; Roberts, L.
|
AIDS |
2011
|
Article
|
|
Substituting nevirapine for efavirenz: risk factors for toxicity in nonnaive patients in a resource-constrained setting [correspondence]
|
van Griensven, J.; Un, P.; Phe, T.; Thai, S.; Lynen, L.
|
AIDS |
2009
|
Letter
|
|
Substituting tenofovir for stavudine in resource-limited settings: there are challenges ahead [correspondence]
|
van Griensven, J.; Lynen, L.; Colebunders, R.
|
AIDS |
2009
|
Letter
|
|
Can response of a pruritic papular eruption to antiretroviral therapy be used as a clinical parameter to monitor virological outcome?
|
Castelnuovo, B.; Byakwaga, H.; Menten, J.; Schaefer, P.; Kamya, M.; Colebunders, R.
|
AIDS |
2008
|
Article
|
|
Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switching
|
Elliott, J. H.; Lynen, L.; Calmy, A.; De Luca, A.; Shafer, R. W.; Zolfo, M.; Clotet, B.; Huffam, S.; Boucher, C. A. B.; Cooper, D. A.; Schapiro, J. M.
|
AIDS |
2008
|
Article
|
|
When to switch for antiretroviral treatment failure in resource-limited settings? [editorial]
|
Vekemans, M.; John, L.; Colebunders, R.
|
AIDS |
2007
|
Editorial
|
|
Unexpected improvement of sexual dysfunction during atazanavir therapy [letter]
|
Colebunders, R.; Moerman, F.; Nöstlinger, C.
|
AIDS |
2006
|
Letter
|
|
The effect of highly active antiretroviral treatment on viral load and antiretroviral drug levels in breast milk [research letter]
|
Colebunders, R.; Hodossy, B.; Burger, D.; Daems, T.; Roelens, K.; Coppens, M.; Van Bulck, B.; Jacquemyn, Y.; Van Wijngaerden, E.; Fransen, K.
|
AIDS |
2005
|
Article
|
|
Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time
|
Ariën, K. K.; Troyer, R. M.; Gali, Y.; Colebunders, R.; Arts, E. J.; Vanham, G.
|
AIDS |
2005
|
Article
|
|
Response to 'Does immune reconstitution promote active tuberculosis in patients receiving highly active antiretroviral therapy?' AIDS, 22 July 2005 [reply]
|
John, L.; Baalwa, J.; Kalimugogo, P.; Nabankema, E.; Castelnuovo, B.; Muhindo, G.; Colebunders, R.; Kambugu, A.
|
AIDS |
2005
|
Letter
|
|
Pegylated interferon alpha-2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients [letter]
|
Callens, S.; Bottieau, E.; Michielsen, P.; Colebunders, R.
|
AIDS |
2004
|
Letter
|
|
Cross-neutralizing antibodies against primary isolates in African women infected with HIV-1 [letter]
|
Donners, H.; Willems, B.; Beirnaert, E.; Colebunders, R.; Davis, D.; van der Groen, G.
|
AIDS |
2002
|
Letter
|
|
Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatment
|
Schrooten, W.; Colebunders, R.; Youle, M.; Molenberghs, G.; Dedes, N.; Koitz, G.; Finazzi, R.; de Mey, I.; Florence, E.; Dreezen, C.
|
AIDS |
2001
|
Article
|
|
Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting
|
Unknown author |
AIDS |
2001
|
Article
|
|
Quality of life in asymptomatic- and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy
|
Nieuwkerk, P. T.; Gisolf, E. H.; Colebunders, R.; Wu, A. W.; Danner, S. A.; Sprangers, M. A.
|
AIDS |
2000
|
Article
|
|
The effect of treatment intensification in HIV-infection: a study comparing treatment with ritonavir/saquinavir and ritonavir/saquinavir/stavudine
|
Gisolf, E. H.; Jurriaans, S.; Pelgrom, J.; van Wanzeele, F.; Van der Ende, M. E.; Brinkman, K.; Borst, M. J.; de Wolf, F.; Japour, A. J.; Danner, S. A.
|
AIDS |
2000
|
Article
|
|
Lest we forget: neuropsychiatry and the new generation anti-HIV drugs [letter]
|
Colebunders, R.; Verdonck, K.
|
AIDS |
1999
|
Letter
|
|
Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe
|
Mocroft, A.; Kirk, O.; Barton, S. E.; Dietrich, M.; Proenca, R.; Colebunders, R.; Pradier, C.; d'Armino Monforte, A.
|
AIDS |
1999
|
Article
|
|
How many different HIV-1 viral load test kits do we need? [letter]
|
Fransen, K.; Colebunders, R.; Heyndrickx, L.; Janssens, W.; van der Groen, G.
|
AIDS |
1998
|
Letter
|
|
Antiretroviral treatment in Africa
|
Colebunders, R.; Karita, E.; Taelman, H.; Mugyenyi, P.
|
AIDS |
1997
|
Article
|